Overview Rating

Speculative

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Technicals Analysis

100

0100

Financials Analysis

0100

AbbVie (NYSE:ABBV) Stock Quotes, Forecast and News Summary

Q: What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	109.00 / 5.47M
Day Range	- - -
52 Wk Range	135.85 - 182.89
Market Cap	$304.29B
P/E Ratio	51.29
Dividend Yield	3.60%
Exchange	NYSE
RSI	56
Short Interest	0.92%
Days to Cover	1.98

Recent News

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Shanthi Rexaline

AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case

AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-client privilege.

Vandana Singh

AbbVie Gains As Market Dips: What You Should Know

The most recent trading session ended with AbbVie (NYSE: ABBV) standing at $169.91, reflecting a +1.05% shift from the previouse trading day's closing. The stock outperformed the S&P 500, which registered a daily loss of 0.88%.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Abbvie Inc

Sector

Health Care

Industry

Biotechnology

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinv...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy AbbVie (ABBV) stock?

You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.

View our list of the best stock brokerages

Who are AbbVie (ABBV) competitors?

Other companies in AbbVie’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for AbbVie (ABBV) stock?

There is no analysis for AbbVie.

What is the forecast for AbbVie (ABBV) stock?

AbbVie has a consensus price target of $173.00.

Current stock price for AbbVie (ABBV)?

The stock price for AbbVie (NYSE: ABBV) is $172.32 last updated July 19, 2024 at 5:26 PM EDT.

Does AbbVie (ABBV) pay a dividend?

A quarterly cash dividend of 1.55 per share of Class A Common Stock. The quarterly cash dividend was payable on August 15, 2024 to stockholders of record on July 15, 2024.

When is AbbVie (NYSE:ABBV) reporting earnings?

AbbVie’s Q2 earnings are confirmed for Thursday, July 25, 2024.

Is AbbVie (ABBV) going to split?

There is no upcoming split for AbbVie.

What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

AbbVie

AbbVie (ABBV) Forecast